{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:31:49Z","timestamp":1790364709388,"version":"4.1.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.carrev.2024.09.010","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T15:53:33Z","timestamp":1726934013000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["ANOCA updated: From pathophysiology to modern clinical practice"],"prefix":"10.1016","volume":"71","author":[{"given":"Kyriakos","family":"Dimitriadis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Pyrpyris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Sakalidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Dri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Iliakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotis","family":"Tatakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Beneki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Fragkoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Aznaouridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.carrev.2024.09.010_bb0005","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa0907272","article-title":"Low diagnostic yield of elective coronary angiography","volume":"362","author":"Patel","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.carrev.2024.09.010_bb0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0002-9343(73)90060-0","article-title":"The anginal syndrome associated with normal coronary arteriograms","volume":"54","author":"Kemp","year":"1973","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.carrev.2024.09.010_bb0015","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and no obstructive coronary artery disease (INOCA)","volume":"135","author":"Bairey Merz","year":"2017","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.carrev.2024.09.010_bb0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008868","article-title":"Ischemia and no obstructive coronary artery disease (INOCA): what is the risk?","volume":"7","author":"Herscovici","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"25","key":"10.1016\/j.carrev.2024.09.010_bb0025","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia","volume":"55","author":"Pepine","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2024.09.010_bb0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2459\/JCM.0000000000000490","article-title":"Clinical role of post-angioplasty hyperemic microvascular resistances in chronic ischemic left ventricular dysfunction","volume":"18","author":"Gorla","year":"2017","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.carrev.2024.09.010_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2018.04.077","article-title":"Clinical and coronary haemodynamic determinants of recurrent chest pain in patients without obstructive coronary artery disease\u2014a pilot study","volume":"267","author":"Sheikh","year":"2018","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.carrev.2024.09.010_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023207","article-title":"Prevalence of coronary microvascular disease and coronary vasospasm in patients with nonobstructive coronary artery disease: systematic review and meta-analysis","volume":"11","author":"Mileva","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.carrev.2024.09.010_bb0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jacc.2018.05.049","article-title":"Coronary microvascular dysfunction and cardiovascular risk in obese patients","volume":"72","author":"Bajaj","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"9785","key":"10.1016\/j.carrev.2024.09.010_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2\u00b77 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2024.09.010_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.carrev.2024.09.010_bb0060","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jacc.2008.05.064","article-title":"Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy","volume":"52","author":"Tsagalou","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.09.010_bb0065","first-page":"9","article-title":"Pathophysiologic basis and diagnostic approaches for ischemia with non-obstructive coronary arteries: a literature review","author":"Fu","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.carrev.2024.09.010_bb0070","doi-asserted-by":"crossref","first-page":"H2096","DOI":"10.1152\/ajpheart.01123.2010","article-title":"Quantification of coronary microvascular resistance using angiographic images for volumetric blood flow measurement: in vivo validation","volume":"300","author":"Zhang","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"45","key":"10.1016\/j.carrev.2024.09.010_bb0075","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1093\/eurheartj\/ehv100","article-title":"Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation","volume":"36","author":"Pries","year":"2015","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tcm.2005.10.002","article-title":"Effects of systemic inflammation on endothelium-dependent vasodilation","volume":"16","author":"Huang","year":"2006","journal-title":"Trends Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.carrev.2024.09.010_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004373","article-title":"Invasive assessment of the coronary microcirculation in reperfused ST-segment\u2013elevation myocardial infarction patients","volume":"10","author":"Bulluck","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.carrev.2024.09.010_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033596","article-title":"Impact of coronary microvascular dysfunction on functional left ventricular remodeling and diastolic dysfunction","volume":"13","author":"Aldujeli","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.carrev.2024.09.010_bb0095","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.3390\/ijms22073373","article-title":"Berries and their polyphenols as a potential therapy for coronary microvascular dysfunction: a mini-review","volume":"22","author":"Najjar","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.carrev.2024.09.010_bb0100","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehw018","article-title":"Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases","volume":"37","author":"Faccini","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2024.09.010_bb0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2016.05.036","article-title":"Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis","volume":"251","author":"Piaserico","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carrev.2024.09.010_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2017.02.035","article-title":"High-sensitivity C-reactive protein is an independent marker of abnormal coronary vasoreactivity in patients with non-obstructive coronary artery disease","volume":"190","author":"Sara","year":"2017","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.carrev.2024.09.010_bb0115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.74.5.955","article-title":"Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm","volume":"74","author":"Yasue","year":"1986","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.carrev.2024.09.010_bb0120","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.CIR.59.5.948","article-title":"Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina","volume":"59","author":"Specchia","year":"1979","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.carrev.2024.09.010_bb0125","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.CIR.62.5.925","article-title":"Provocation of coronary artery spasm by the cold pressor test. Hemodynamic, arteriographic and quantitative angiographic observations","volume":"62","author":"Raizner","year":"1980","journal-title":"Circulation"},{"issue":"34","key":"10.1016\/j.carrev.2024.09.010_bb0130","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1093\/eurheartj\/ehz915","article-title":"Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction","volume":"41","author":"Ford","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2024.09.010_bb0135","article-title":"Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries","volume":"ehw448","author":"Odaka","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1253\/circj.CJ-16-1002","article-title":"Coronary microvascular dysfunction\u2014epidemiology, pathogenesis, prognosis, diagnosis, risk factors and therapy","volume":"81","author":"Chen","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2024.09.010_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2045-824X-6-19","article-title":"Ageing and microvasculature","volume":"6","author":"Scioli","year":"2014","journal-title":"Vasc Cell"},{"issue":"3","key":"10.1016\/j.carrev.2024.09.010_bb0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/1570161113666150206110512","article-title":"Microcirculation in hypertension: an update on clinical significance and therapy","volume":"13","author":"Tsioufis","year":"2015","journal-title":"Curr Vasc Pharmacol"},{"issue":"12","key":"10.1016\/j.carrev.2024.09.010_bb0155","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14728222.2011.642868","article-title":"Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction","volume":"15","author":"Tsioufis","year":"2011","journal-title":"Expert Opin Ther Targets"},{"issue":"8","key":"10.1016\/j.carrev.2024.09.010_bb0160","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0735-1097(03)00166-9","article-title":"Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes","volume":"41","author":"Di Carli","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0735-1097(00)00697-5","article-title":"Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia","volume":"36","author":"Kaufmann","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.carrev.2024.09.010_bb0170","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1161\/01.CIR.0000147827.43912.AE","article-title":"High-density lipoprotein stimulates myocardial perfusion in vivo","volume":"110","author":"Levkau","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.carrev.2024.09.010_bb0175","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.jacc.2004.12.084","article-title":"Insights from the NHLBI-sponsored women\u2019s ischemia syndrome evaluation (WISE) study","volume":"47","author":"Bairey Merz","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2024.09.010_bb0180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ahj.2007.10.019","article-title":"Angina with \u201cnormal\u201d coronary arteries: sex differences in outcomes","volume":"155","author":"Humphries","year":"2008","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcmg.2022.06.015","article-title":"Ischemia with nonobstructive coronary arteries","volume":"16","author":"Reynolds","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.carrev.2024.09.010_bb0190","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.cjca.2022.07.005","article-title":"One-year prospective follow-up of women with INOCA and MINOCA at a Canadian Women\u2019s Heart Centre","volume":"38","author":"Parvand","year":"2022","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2024.09.010_bb0195","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/clc.19","article-title":"Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women\u2019s Ischemia Syndrome Evaluation (WISE)","volume":"30","author":"Wessel","year":"2007","journal-title":"Clin Cardiol"},{"issue":"12","key":"10.1016\/j.carrev.2024.09.010_bb0200","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jacc.2023.06.043","article-title":"Comprehensive management of ANOCA, part 1\u2014definition, patient population, and diagnosis","volume":"82","author":"Samuels","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.carrev.2024.09.010_bb0205","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.105.609990","article-title":"The economic burden of angina in women with suspected ischemic heart disease","volume":"114","author":"Shaw","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0210","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ahj.2013.03.015","article-title":"Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease","volume":"166","author":"Sedlak","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2024.09.010_bb0215","article-title":"Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study","volume":"ehw548","author":"Nielsen","year":"2016","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.carrev.2024.09.010_bb0220","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jcmg.2021.01.041","article-title":"Functional and economic impact of INOCA and influence of coronary microvascular dysfunction","volume":"14","author":"Schumann","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.carrev.2024.09.010_bb0225","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.echo.2020.01.007","article-title":"Coronary flow velocity reserve reduction is associated with cardiovascular, cancer, and noncancer, noncardiovascular mortality","volume":"33","author":"Gaibazzi","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"10.1016\/j.carrev.2024.09.010_bb0230","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4244\/EIJ-D-22-00043","article-title":"Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry","volume":"18","author":"Boerhout","year":"2022","journal-title":"EuroIntervention"},{"issue":"10","key":"10.1016\/j.carrev.2024.09.010_bb0235","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.jcmg.2021.02.023","article-title":"Coronary microvascular dysfunction assessed by pressure wire and CMR after STEMI predicts long-term outcomes","volume":"14","author":"Scarsini","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"24","key":"10.1016\/j.carrev.2024.09.010_bb0240","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1161\/CIRCULATIONAHA.112.000298","article-title":"Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention","volume":"127","author":"Fearon","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.carrev.2024.09.010_bb0245","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacc.2009.07.059","article-title":"The hypertensive heart","volume":"55","author":"Raman","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.carrev.2024.09.010_bb0250","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.carrev.2024.09.010_bb0255","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrcardio.2014.83","article-title":"The pathophysiology of heart failure with preserved ejection fraction","volume":"11","author":"Borlaug","year":"2014","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2024.09.010_bb0260","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.carrev.2024.09.010_bb0265","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002649","article-title":"Impairment of coronary flow reserve evaluated by phase contrast cine-magnetic resonance imaging in patients with heart failure with preserved ejection fraction","volume":"5","author":"Kato","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.carrev.2024.09.010_bb0270","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002562","article-title":"Reduced myocardial flow in heart failure patients with preserved ejection fraction","volume":"9","author":"Srivaratharajah","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"25","key":"10.1016\/j.carrev.2024.09.010_bb0275","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1093\/eurheartj\/ehaa191","article-title":"Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure","volume":"41","author":"Zhou","year":"2020","journal-title":"Eur Heart J"},{"issue":"37","key":"10.1016\/j.carrev.2024.09.010_bb0280","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.carrev.2024.09.010_bb0285","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ccd.30990","article-title":"Coronary microvascular dysfunction assessment: a comparative analysis of procedural aspects","volume":"103","author":"Merdler","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-8703(49)90788-7","article-title":"The measurement of coronary blood flow, oxygen consumption, and efficiency of the left ventricle in man","volume":"38","author":"Bing","year":"1949","journal-title":"Am Heart J"},{"issue":"5128","key":"10.1016\/j.carrev.2024.09.010_bb0295","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/bmj.1.5128.985","article-title":"Exercise and heart disease","volume":"1","author":"Donald","year":"1959","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.carrev.2024.09.010_bb0300","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/hrt.29.3.422","article-title":"Oxygen extraction rate of the myocardium at rest and on exercise in various conditions","volume":"29","author":"Binak","year":"1967","journal-title":"Br Heart J"},{"issue":"46","key":"10.1016\/j.carrev.2024.09.010_bb0305","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1093\/eurheartj\/ehx669","article-title":"Coronary autoregulation and assessment of stenosis severity without pharmacological vasodilation","volume":"39","author":"de Waard","year":"2018","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.carrev.2024.09.010_bb0310","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.carrev.2024.09.010_bb0315","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ejhf.1671","article-title":"Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"22","author":"Yang","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"10.1016\/j.carrev.2024.09.010_bb0320","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehab775","article-title":"Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis","volume":"43","author":"Kelshiker","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0325","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/CIRCULATIONAHA.123.066680","article-title":"ChaMP-CMD: a phenotype-blinded, randomized controlled, cross-over trial","volume":"149","author":"Sinha","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.carrev.2024.09.010_bb0330","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1152\/japplphysiol.00684.2005","article-title":"Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia","volume":"101","author":"Martin","year":"2006","journal-title":"J Appl Physiol"},{"issue":"7","key":"10.1016\/j.carrev.2024.09.010_bb0335","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4244\/EIJ-D-20-00853","article-title":"Prognostic impact and clinical outcomes of coronary flow reserve and hyperaemic microvascular resistance","volume":"17","author":"Toya","year":"2021","journal-title":"EuroIntervention"},{"issue":"13","key":"10.1016\/j.carrev.2024.09.010_bb0340","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4244\/EIJY20M07_01","article-title":"An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation endorsed by Coronary Vasomotor Disorders Internati","volume":"16","author":"Kunadian","year":"2021","journal-title":"EuroIntervention"},{"issue":"19","key":"10.1016\/j.carrev.2024.09.010_bb0345","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2019.08.1056","article-title":"Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease","volume":"74","author":"Suda","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.09.010_bb0350","first-page":"11","article-title":"Diagnostic and prognostic value of angiography-derived index of microvascular resistance: a systematic review and meta-analysis","author":"Wang","year":"2024","journal-title":"Front Cardiovasc Med"},{"issue":"15","key":"10.1016\/j.carrev.2024.09.010_bb0355","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jacc.2021.08.017","article-title":"Microvascular resistance reserve for assessment of coronary microvascular function","volume":"78","author":"De Bruyne","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2024.09.010_bb0360","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jcin.2022.12.012","article-title":"Microvascular resistance reserve to assess microvascular dysfunction in ANOCA patients","volume":"16","author":"de Vos","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"30","key":"10.1016\/j.carrev.2024.09.010_bb0365","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1093\/eurheartj\/ehad378","article-title":"Microvascular resistance reserve: diagnostic and prognostic performance in the ILIAS registry","volume":"44","author":"Boerhout","year":"2023","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.carrev.2024.09.010_bb0370","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jcin.2024.01.008","article-title":"Prognostic implications of microvascular resistance reserve in symptomatic patients with intermediate coronary stenosis","volume":"17","author":"Lee","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.carrev.2024.09.010_bb0375","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jcin.2024.03.024","article-title":"The impact of microvascular resistance reserve on the outcome of patients with STEMI","volume":"17","author":"Tsai","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"10.1016\/j.carrev.2024.09.010_bb0380","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4244\/EIJY20M07_01","volume":"16","author":"Kunadian","year":"2021","journal-title":"EuroIntervention"},{"issue":"9","key":"10.1016\/j.carrev.2024.09.010_bb0385","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jcin.2024.03.007","article-title":"Multivessel coronary function testing increases diagnostic yield in patients with angina and nonobstructive coronary arteries","volume":"17","author":"Rehan","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.carrev.2024.09.010_bb0390","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.carrev.2024.09.010_bb0395","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jacc.2023.06.043","article-title":"Comprehensive management of ANOCA, part 1\u2014definition, patient population, and diagnosis","volume":"82","author":"Samuels","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.carrev.2024.09.010_bb0400","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4244\/EIJ-D-19-00520","article-title":"Sex-specific differences in coronary blood flow and flow velocity reserve in symptomatic patients with non-obstructive disease","volume":"16","author":"Corban","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.09.010_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131832","article-title":"Impact of sex on the assessment of the microvascular resistance reserve","volume":"402","author":"Boerhout","year":"2024","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.carrev.2024.09.010_bb0410","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.4244\/EIJ-D-23-00778","article-title":"Effects of age on microvascular function in patients with normal coronary arteries","volume":"20","author":"Jansen","year":"2024","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1016\/j.carrev.2024.09.010_bb0415","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacc.2024.05.004","article-title":"The influence of epicardial resistance on microvascular resistance reserve","volume":"84","author":"Mahendiran","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2024.09.010_bb0420","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2023.10.034","article-title":"Rethinking false positive exercise electrocardiographic stress tests by assessing coronary microvascular function","volume":"83","author":"Sinha","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.carrev.2024.09.010_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2024.02.048","article-title":"Exercise electrocardiographic stress test for diagnosing coronary microvascular dysfunction","volume":"83","author":"Dimitriadis","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"33","key":"10.1016\/j.carrev.2024.09.010_bb0430","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.carrev.2024.09.010_bb0435","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","article-title":"In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Hea","volume":"162","author":"Pauly","year":"2011","journal-title":"Am Heart J"},{"issue":"19","key":"10.1016\/j.carrev.2024.09.010_bb0440","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIRCULATIONAHA.108.773747","article-title":"Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography","volume":"117","author":"Ballantyne","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.carrev.2024.09.010_bb0445","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pharmthera.2014.06.008","article-title":"Pharmacological approaches to coronary microvascular dysfunction","volume":"144","author":"Guarini","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"19","key":"10.1016\/j.carrev.2024.09.010_bb0450","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey Merz","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2024.09.010_bb0455","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2018.09.081","article-title":"Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women\u2019s Ischemia Syndrome Evaluation\u2013Coronary Vascular Dysfunction ancillary study","volume":"276","author":"Rambarat","year":"2019","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0460","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2010.11.035","article-title":"Ivabradine improves coronary flow reserve in patients with stable coronary artery disease","volume":"215","author":"Skalidis","year":"2011","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0465","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2013.02.045","article-title":"Effects of ivabradine and ranolazine in patients with microvascular angina pectoris","volume":"112","author":"Villano","year":"2013","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.carrev.2024.09.010_bb0470","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.clinthera.2019.08.008","article-title":"Effects of the antianginal drugs ranolazine, nicorandil, and ivabradine on coronary microvascular function in patients with nonobstructive coronary artery disease: a meta-analysis of randomized controlled trials","volume":"41","author":"Zhu","year":"2019","journal-title":"Clin Ther"},{"issue":"suppl_1","key":"10.1016\/j.carrev.2024.09.010_bb0475","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehx501.P887","article-title":"P887Trimetazidine improves symptoms and reduces microvascular dysfunction in patients with microvascular angina","volume":"38","author":"Leonova","year":"2017","journal-title":"Eur Heart J"},{"issue":"01","key":"10.1016\/j.carrev.2024.09.010_bb0480","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF01616842","article-title":"The effect of trimetazidine in the treatment of microvascular angina","volume":"8","author":"Nalbantgil","year":"2011","journal-title":"Int J Angiol"},{"issue":"11","key":"10.1016\/j.carrev.2024.09.010_bb0485","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and no obstructive coronary artery disease (INOCA)","volume":"135","author":"Bairey Merz","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.09.010_bb0490","article-title":"The central nervous system and psychosocial factors in primary microvascular angina","volume":"1","author":"Pizzi","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.carrev.2024.09.010_bb0495","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/eurheartj\/ehi089","article-title":"Effect of spinal cord stimulation on spontaneous and stress-induced angina and \u201cischemia-like\u201d ST-segment depression in patients with cardiac syndrome X","volume":"26","author":"Lanza","year":"2005","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.carrev.2024.09.010_bb0500","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1525-1403.2012.00430.x","article-title":"Effect of spinal cord stimulation in patients with refractory angina: evidence from observational studies","volume":"15","author":"Lanza","year":"2012","journal-title":"Neuromodulation"},{"key":"10.1016\/j.carrev.2024.09.010_bb0505","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2022.11.009","article-title":"Ischemia and no obstructive coronary arteries (INOCA): a narrative review","volume":"363","author":"Mehta","year":"2022","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.carrev.2024.09.010_bb0510","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1090-3801(03)00022-3","article-title":"Electrical neuromodulation improves myocardial perfusion and ameliorates refractory angina pectoris in patients with syndrome X: fad or future?","volume":"7","author":"Jessurun","year":"2003","journal-title":"Eur J Pain"},{"issue":"2","key":"10.1016\/j.carrev.2024.09.010_bb0515","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/01.CIR.89.2.694","article-title":"Effect of transcutaneous electrical nerve stimulation on coronary blood flow","volume":"89","author":"Chauhan","year":"1994","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.carrev.2024.09.010_bb0520","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijcard.2008.03.022","article-title":"Enhanced external counterpulsation is an effective treatment for syndrome X","volume":"135","author":"Kronhaus","year":"2009","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0525","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0735-1097(00)01095-0","article-title":"Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease","volume":"37","author":"Urano","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.09.010_bb0530","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.carrev.2024.03.021","article-title":"Coronary microvascular disease registry (CMDR): study design and rationale","volume":"66","author":"Case","year":"2024","journal-title":"Cardiovasc Revasc Med"},{"issue":"6","key":"10.1016\/j.carrev.2024.09.010_bb0535","article-title":"Determining the cause of coronary vasomotor disorders in patients with ischemia and nonobstructive coronary arteries: design and rationale of the DISCOVER INOCA prospective, multicenter registry","volume":"3","author":"Shah","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"3","key":"10.1016\/j.carrev.2024.09.010_bb0540","first-page":"143","article-title":"ESC working group position paper on myocardial infarction with non-obstructive coronary arteries","volume":"38","author":"Agewall","year":"2017","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.carrev.2024.09.010_bb0545","first-page":"284","article-title":"Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need","volume":"104","author":"Ford","year":"2018","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.carrev.2024.09.010_bb0550","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcin.2020.12.025","article-title":"Prognostic links between OCT-delineated coronary morphologies and coronary functional abnormalities in patients with INOCA","volume":"14","author":"Nishimiya","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0555","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12933-018-0745-5","article-title":"Potential mechanisms responsible for cardioprotective effects of sodium\u2013glucose co-transporter 2 inhibitors","volume":"17","author":"Lahnwong","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"10354","key":"10.1016\/j.carrev.2024.09.010_bb0560","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0565","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12933-021-01222-9","article-title":"Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA","volume":"20","author":"Paolisso","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0570","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12933-019-0820-6","article-title":"SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob\/ob\u2212\/\u2212 mice","volume":"18","author":"Adingupu","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"10.1016\/j.carrev.2024.09.010_bb0575","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.7150\/thno.75121","article-title":"SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia\/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways","volume":"12","author":"Ma","year":"2022","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.carrev.2024.09.010_bb0580","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2019.04.003","article-title":"Cardiac microvascular endothelial enhancement of cardiomyocyte function is impaired by inflammation and restored by empagliflozin","volume":"4","author":"Juni","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"15","key":"10.1016\/j.carrev.2024.09.010_bb0585","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020418","article-title":"Effects of empagliflozin on myocardial flow reserve in patients with type 2 diabetes mellitus: the SIMPLE trial","volume":"10","author":"J\u00fcrgens","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.carrev.2024.09.010_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263481","article-title":"Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus\u2013a randomized, placebo-controlled cross-over study. Fukumoto Y, ed","volume":"17","author":"Suhrs","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.carrev.2024.09.010_bb0595","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcvp\/pvad053","article-title":"The effect of SGLT2 inhibitors on the endothelium and the microcirculation: from bench to bedside and beyond","author":"Dimitriadis","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.carrev.2024.09.010_bb0600","article-title":"Mechanistic study of the effect of endothelin SNPs in microvascular angina \u2013 protocol of the PRIZE endothelin sub-study","volume":"39","author":"Abraham","year":"2022","journal-title":"IJC Heart Vasc"},{"issue":"3","key":"10.1016\/j.carrev.2024.09.010_bb0605","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCRESAHA.121.319644","article-title":"IMPROvE-CED trial: intracoronary autologous CD34+ cell therapy for treatment of coronary endothelial dysfunction in patients with angina and nonobstructive coronary arteries","volume":"130","author":"Corban","year":"2022","journal-title":"Circ Res"},{"issue":"18","key":"10.1016\/j.carrev.2024.09.010_bb0610","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jcin.2017.06.062","article-title":"First experience with the coronary sinus reducer system for the management of refractory angina in patients without obstructive coronary artery disease","volume":"10","author":"Giannini","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.09.010_bb0615","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.carrev.2023.07.008","article-title":"Coronary sinus narrowing therapy: a \u201creducer\u201d for angina and beyond","volume":"57","author":"Dimitriadis","year":"2023","journal-title":"Cardiovasc Revasc Med"},{"issue":"2","key":"10.1016\/j.carrev.2024.09.010_bb0620","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/HJH.0000000000000408","article-title":"Effects of multielectrode renal denervation on cardiac and neurohumoral adaptations in resistant hypertension with cardiac hypertrophy","volume":"33","author":"Tsioufis","year":"2015","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0625","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jjcc.2008.04.002","article-title":"Endoscopic thoracic sympathectomy as a novel strategy for vasospastic angina refractory to medical treatments","volume":"52","author":"Yoshida","year":"2008","journal-title":"J Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262290","article-title":"Relationship between hypertension and non-obstructive coronary artery disease in chronic coronary syndrome (the NORIC registry). Pizzi C, ed","volume":"17","author":"Berge","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.carrev.2024.09.010_bb0635","doi-asserted-by":"crossref","DOI":"10.2459\/JCM.0000000000001609","article-title":"Impact of renal denervation on patients with coronary microvascular dysfunction: study rationale and design","author":"Migliaro","year":"2024","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.carrev.2024.09.010_bb2005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijcard.2020.01.053","article-title":"Resting coronary velocity and myocardial performance in women with impaired coronary flow reserve: results from the Women\u2019s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study","volume":"309","author":"Suppogu","year":"2020","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2024.09.010_bb2010","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/eurheartj\/ehaa944","article-title":"Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study","volume":"42","author":"Schroder","year":"2021","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.carrev.2024.09.010_bb2015","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.carrev.2024.09.010_bb2020","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.jcmg.2018.08.018","article-title":"Global coronary flow reserve measured during stress cardiac magnetic resonance imaging is an independent predictor of adverse cardiovascular events","volume":"12","author":"Indorkar","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb2025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcin.2019.11.001","article-title":"1-year outcomes of angina management guided by invasive coronary function testing (CorMicA)","volume":"13","author":"Ford","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.carrev.2024.09.010_bb2030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00259-023-06448-1","article-title":"Integrated myocardial flow reserve (iMFR) assessment: diffuse atherosclerosis and microvascular dysfunction are more strongly associated with mortality than focally impaired perfusion","volume":"51","author":"Moody","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924006729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924006729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T21:22:29Z","timestamp":1741036949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838924006729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":133,"alternative-id":["S1553838924006729"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2024.09.010","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ANOCA updated: From pathophysiology to modern clinical practice","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2024.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}